Citius Oncology files prospectus supplement to update S-1 registration statement following 10-Q filing

CITIUS ONCOLOGY, INC.

Prospectus supplement filed August 18, 2025; original S-1 effective July 15, 2025.
Public offering of common stock and warrants closed July 17, 2025.
Supplement needed because Citius Oncology not yet eligible to incorporate 10-Q by reference into S-1.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.